Log In
BCIQ
Print this Print this
 

F351

  Manage Alerts
Collapse Summary General Information
Company GNI Group Ltd.
DescriptionSmall molecule non-steroidal anti-fibrosis compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCirrhosis
Indication DetailsTreat liver fibrosis and cirrhosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today